Literature DB >> 11122257

IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE).

B Bussolati1, C Rollino, F Mariano, F Quarello, G Camussi.   

Abstract

IL-10 displays modulatory properties on the synthesis of platelet-activating factor (PAF), a potent inflammatory mediator of vascular injury. Despite the fact that IL-10 is considered to be an anti-inflammatory cytokine, IL-10 levels correlate with disease activity in SLE. Moreover, in SLE IL-10 is unable to exert its immunosuppressive and anti-inflammatory effects. We have investigated the ability of IL-10 to stimulate PAF production from monocytes of SLE patients. Spontaneous and IL-10-stimulated PAF production by peripheral blood monocytes was measured in active (n = 13) and inactive (n = 14) SLE patients and in 15 normal control subjects. We observed that monocytes derived from patients with active SLE, but not from controls or inactive SLE, spontaneously produced significant amounts of PAF. Moreover, IL-10 enhanced the synthesis of PAF from monocytes of active SLE patients only. IL-10-induced PAF production correlated with the severity of the disease and with the extent of proteinuria. These results indicate that IL-10 only stimulates the synthesis of PAF from monocytes of SLE patients when immunologically active, suggesting that IL-10 may possess a paradoxical proinflammatory effect in SLE by promoting the production of PAF, a secondary mediator of inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122257      PMCID: PMC1905813          DOI: 10.1046/j.1365-2249.2000.01392.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Inquiry into murine and human lupus.

Authors:  D M Klinman; A D Steinberg
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

Review 3.  Structural and (patho)physiological diversity of PAF.

Authors:  R N Pinckard; D S Woodard; H J Showell; M J Conklyn; M J Novak; L M McManus
Journal:  Clin Rev Allergy       Date:  1994

Review 4.  Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.

Authors:  G Camussi
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

5.  Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes.

Authors:  B Bussolati; F Mariano; G Montrucchio; G Piccoli; G Camussi
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

Review 6.  Immunoregulatory circuits and potential treatment of connective tissue diseases.

Authors:  J Alcocer-Varela; L Llorente; D Alarcón-Segovia
Journal:  Int Arch Allergy Immunol       Date:  1996-12       Impact factor: 2.749

7.  Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood.

Authors:  E Hagiwara; M F Gourley; S Lee; D K Klinman
Journal:  Arthritis Rheum       Date:  1996-03

8.  Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis.

Authors:  P Chomarat; J Banchereau; P Miossec
Journal:  Arthritis Rheum       Date:  1995-08

9.  Flaxseed: a potential treatment for lupus nephritis.

Authors:  W F Clark; A Parbtani; M W Huff; E Spanner; H de Salis; I Chin-Yee; D J Philbrick; B J Holub
Journal:  Kidney Int       Date:  1995-08       Impact factor: 10.612

10.  Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

Authors:  L Llorente; W Zou; Y Levy; Y Richaud-Patin; J Wijdenes; J Alcocer-Varela; B Morel-Fourrier; J C Brouet; D Alarcon-Segovia; P Galanaud; D Emilie
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  9 in total

1.  Dietary resistant starch type 4-derived butyrate attenuates nuclear factor-kappa-B1 through modulation of histone H3 trimethylation at lysine 27.

Authors:  Yi Liu; Bijaya Upadhyaya; Ali Reza Fardin-Kia; Robert M Juenemann; Moul Dey
Journal:  Food Funct       Date:  2016-09-14       Impact factor: 5.396

2.  Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.

Authors:  Yu-Hsin Hsueh; Hung-Wen Chen; Bi-Jhen Syu; Chia-I Lin; Patrick S C Leung; M Eric Gershwin; Ya-Hui Chuang
Journal:  J Autoimmun       Date:  2018-09-28       Impact factor: 7.094

3.  Platelet-activating factor antagonists decrease follicular dendritic-cell stimulation of human B lymphocytes.

Authors:  Isaac Halickman; Yolande Bastien; Qianli Zhuang; Monty B Mazer; Baruch Toledano; Bruce D Mazer
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

Review 4.  Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.

Authors:  Xiaoyu Hu; Soumya D Chakravarty; Lionel B Ivashkiv
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 5.  The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.

Authors:  Wen-Tao Ma; Fei Gao; Kui Gu; De-Kun Chen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

6.  Cytokine expression profile of dengue patients at different phases of illness.

Authors:  Anusyah Rathakrishnan; Seok Mui Wang; Yongli Hu; Asif M Khan; Sasheela Ponnampalavanar; Lucy Chai See Lum; Rishya Manikam; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  The anti-inflammatory mechanisms of Hsp70.

Authors:  Thiago J Borges; Lotte Wieten; Martijn J C van Herwijnen; Femke Broere; Ruurd van der Zee; Cristina Bonorino; Willem van Eden
Journal:  Front Immunol       Date:  2012-05-04       Impact factor: 7.561

8.  No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis.

Authors:  Yves Denizot; Eric Liozon; Laurence Guglielmi; Kim Ly; Pascale Soria; Véronique Loustaud; Elisabeth Vidal; Marie Odile Jauberteau
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

Review 9.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.